The use of Machine Learning and AI in Antibiotic Drug Design
By Cambridge Alliance on Medicines Safety
A seminar by, Prof Paul Finn, CEO of Oxford Drug Design, discussing the use of Machine Learning and AI in Antibiotic Drug Design.
A seminar by, Prof Paul Finn, CEO of Oxford Drug Design, discussing the use of Machine Learning and AI in Antibiotic Drug Design.